Search
SOLACI Congress
HomeStructural heart diseaseValvular Aortic valve

Valvular Aortic valve

View Category

Structural heart disease

Stroke Predictors in TAVR: CoreValve vs. Sapien

A comprehensive analyzis of cerebrovascular events in major randomized controlled studies on transcatheter aortic valve replacement (TAVR)...
solaci -
Learn More
Structural heart disease

Paravalvular Insufficiency After TAVR: A Better Predictor of Endocarditis

Data from this large international registry associate endocarditis after a transcatheter aortic valve replacement (TAVR) with high...
solaci -
Learn More
Structural heart disease

New TAVR Devices: Better Results in Bicuspids

Courtesy of del Dr. Carlos Fava.   The bicuspid aortic valve is highly anatomically challenging because of valve asymmetric...
solaci -
Learn More
Structural heart disease

SAPIEN 3: Low One-Year-Mortality in High Risk or Inoperable Patients

In the first PARTNER trial (Placement of Aortic Transcatheter Valves), mortality at one year was 24% for...
solaci -
Learn More
Structural heart disease

Bivalirudin or Heparin to Decrease Cerebral Embolization Post TAVI?

  Cerebral embolization is a relatively frequent complication during transcatheter aortic valve replacement (TAVR). The hypothesis behind this...
solaci -
Learn More
Structural heart disease

Pre-TAVI Mitral Regurgitation Is Associated with Higher Mortality

Courtesy of Dr. Carlos Fava.   This study sought to analyze the clinical impact and the level of improvement of...
solaci -
Learn More
Structural heart disease

Sex Specific Outcomes: Women after TAVI

Courtesy of Dr. Carlos Fava. The benefits of transcatheter aortic valve implantation (TAVI) have been widely shown, but there...
solaci -
Learn More
Structural heart disease

Low BMI Is a Predictor of Death for TAVI

Courtesy of Dr. Carlos Fava.     Body mass index (BMI) has always played an important role in heart surgery....
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

AHA 2024 | VANISH2 Trial

Dr. Omar Tupayachi - 0
Cardiac defibrillator implants (CDIs) have been shown to improve survival in patients with ischemic cardiomyopathy and ventricular tachycardia (VT). However, approximately one third of...

AHA 2024 | SUMMIT

Dr. Omar Tupayachi - 0
It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Dr. Omar Tupayachi - 0
Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Institutional News

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy